UB Paderborn / Katalog / Suche / in CDI

Technological and practical challenges of dry powder inhalers and formulations

Advanced drug delivery reviews, 2014-08, Vol.75, p.18-31

2014

Link zum Volltext

Verfügbarkeit prüfen

Dry powder inhalation: past, present and future

Expert opinion on drug delivery, 2017-04, Vol.14 (4), p.499-512

2017

Link zum Volltext

Verfügbarkeit prüfen

Covalent immobilization of glucose oxidase on amino MOFs via post-synthetic modification

RSC advances, 2016, Vol.6 (109), p.108051-108055

2016

Link zum Volltext

Verfügbarkeit prüfen

Tolerability and pharmacokinetic evaluation of inhaled dry powder hydroxychloroquine in healthy volunteers

PloS one, 2022-08, Vol.17 (8), p.e0272034-e0272034

2022

Link zum Volltext

Verfügbarkeit prüfen

Colistin dry powder inhalation with the Twincer™: An effective and more patient friendly alternative to nebulization

PloS one, 2020-09, Vol.15 (9), p.e0239658-e0239658

2020

Link zum Volltext

Verfügbarkeit prüfen

In vitro evaluation of the DP-4M PennCentury™ insufflator

European journal of pharmaceutics and biopharmaceutics, 2014-09, Vol.88 (1), p.153-159

2014

Link zum Volltext

Verfügbarkeit prüfen

The Cyclops for pulmonary delivery of aminoglycosides; a new member of the Twincer™ family

European journal of pharmaceutics and biopharmaceutics, 2015-02, Vol.90, p.8-15

2015

Link zum Volltext

Verfügbarkeit prüfen

Developments and strategies for inhaled antibiotic drugs in tuberculosis therapy: A critical evaluation

European journal of pharmaceutics and biopharmaceutics, 2014-01, Vol.86 (1), p.23-30

2014

Link zum Volltext

Verfügbarkeit prüfen

Learning from Parkinson’s patients: Usability of the Cyclops dry powder inhaler

International journal of pharmaceutics, 2019-08, Vol.567, p.118493-118493, Article 118493

2019

Link zum Volltext

Verfügbarkeit prüfen

Can Patients with Parkinson's Disease Use Dry Powder Inhalers during Off Periods?

PloS one, 2015-07, Vol.10 (7), p.e0132714-e0132714

2015

Link zum Volltext

Verfügbarkeit prüfen

Copper-Heparin Inhalation Therapy To Repair Emphysema: A Scientific Rationale

International journal of chronic obstructive pulmonary disease, 2019-11, Vol.14, p.2587-2602

2019

Link zum Volltext

Verfügbarkeit prüfen

Steady-state kinetics of the tungsten containing aldehyde: ferredoxin oxidoreductases from the hyperthermophilic archaeon Pyrococcus furiosus

Journal of biotechnology, 2019-12, Vol.306, p.142-148

Hagedoorn, Peter-Leon

2019

Link zum Volltext

Verfügbarkeit prüfen

Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique

International journal of pharmaceutics, 2002-12, Vol.249 (1), p.219-231

2002

Link zum Volltext

Verfügbarkeit prüfen

Air classifier technology (ACT) in dry powder inhalation Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation

International journal of pharmaceutics, 2003-07, Vol.260 (2), p.201-216

2003

Link zum Volltext

Verfügbarkeit prüfen

Air classifier technology (ACT) in dry powder inhalation: Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures

International journal of pharmaceutics, 2003-07, Vol.260 (2), p.187-200

2003

Link zum Volltext

Verfügbarkeit prüfen

On the relationship between affinity for molecular hydrogen and the physiological directionality of hydrogenases

Biochemical Society transactions, 2005-02, Vol.33 (Pt 1), p.12

2005

Link zum Volltext

Verfügbarkeit prüfen

A critical evaluation of the relevant parameters for drug redispersion from adhesive mixtures during inhalation

International journal of pharmaceutics, 2005-04, Vol.294 (1), p.173-184

2005

Link zum Volltext

Verfügbarkeit prüfen

Air classifier technology (ACT) in dry powder inhalation. Part 4. Performance of air classifier technology in the Novolizer® multi-dose dry powder inhaler

International journal of pharmaceutics, 2006-03, Vol.310 (1-2), p.81-89

2006

Link zum Volltext

Verfügbarkeit prüfen

Air classifier technology (ACT) in dry powder inhalation. Part 3. Design and development of an air classifier family for the Novolizer® multi-dose dry powder inhaler

International journal of pharmaceutics, 2006-03, Vol.310 (1-2), p.72-80

2006

Link zum Volltext

Verfügbarkeit prüfen

Pyrococcus furiosus ferredoxin is a functional dimer

FEBS letters, 2002-11, Vol.531 (2), p.335-338

2002

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the Chlorate Reductase from Pseudomonas chloritidismutans

Journal of Bacteriology, 2003-05, Vol.185 (10), p.3210-3213

2003

Link zum Volltext

Verfügbarkeit prüfen

Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle

European journal of pharmaceutics and biopharmaceutics, 2002-07, Vol.54 (1), p.17-24

2002

Link zum Volltext

Verfügbarkeit prüfen

Novel structure and redox chemistry of the prosthetic groups of the iron-sulfur flavoprotein sulfide dehydrogenase from Pyrococcus furiosus; evidence for a [2Fe-2S] cluster with Asp(Cys)3 ligands

Journal of biological inorganic chemistry, 2000-08, Vol.5 (4), p.527-534

2000

Link zum Volltext

Verfügbarkeit prüfen

Crystal Structure of Chlorite Dismutase, a Detoxifying Enzyme Producing Molecular Oxygen

Journal of molecular biology, 2009-03, Vol.387 (1), p.192-206

2009

Link zum Volltext

Verfügbarkeit prüfen

Phosphate accelerates displacement of Fe(III) by Fe(II) in the ferroxidase center of Pyrococcus furiosus ferritin

FEBS letters, 2013-01, Vol.587 (2), p.220-225

2013

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Technological and practical challenges of dry powder inhalers and formulations

Dry powder inhalation: past, present and future

Covalent immobilization of glucose oxidase on amino MOFs via post-synthetic modification

Tolerability and pharmacokinetic evaluation of inhaled dry powder hydroxychloroquine in healthy volunteers

Colistin dry powder inhalation with the Twincer™: An effective and more patient friendly alternative to nebulization

In vitro evaluation of the DP-4M PennCentury™ insufflator

The Cyclops for pulmonary delivery of aminoglycosides; a new member of the Twincer™ family

Developments and strategies for inhaled antibiotic drugs in tuberculosis therapy: A critical evaluation

Learning from Parkinson’s patients: Usability of the Cyclops dry powder inhaler

Can Patients with Parkinson's Disease Use Dry Powder Inhalers during Off Periods?

Copper-Heparin Inhalation Therapy To Repair Emphysema: A Scientific Rationale

Steady-state kinetics of the tungsten containing aldehyde: ferredoxin oxidoreductases from the hyperthermophilic archaeon Pyrococcus furiosus

Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique

Air classifier technology (ACT) in dry powder inhalation Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation

Air classifier technology (ACT) in dry powder inhalation: Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures

On the relationship between affinity for molecular hydrogen and the physiological directionality of hydrogenases

A critical evaluation of the relevant parameters for drug redispersion from adhesive mixtures during inhalation

Air classifier technology (ACT) in dry powder inhalation. Part 4. Performance of air classifier technology in the Novolizer® multi-dose dry powder inhaler

Air classifier technology (ACT) in dry powder inhalation. Part 3. Design and development of an air classifier family for the Novolizer® multi-dose dry powder inhaler

Pyrococcus furiosus ferredoxin is a functional dimer

Characterization of the Chlorate Reductase from Pseudomonas chloritidismutans

Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle

Novel structure and redox chemistry of the prosthetic groups of the iron-sulfur flavoprotein sulfide dehydrogenase from Pyrococcus furiosus; evidence for a [2Fe-2S] cluster with Asp(Cys)3 ligands

Crystal Structure of Chlorite Dismutase, a Detoxifying Enzyme Producing Molecular Oxygen

Phosphate accelerates displacement of Fe(III) by Fe(II) in the ferroxidase center of Pyrococcus furiosus ferritin

Suchergebnisse filtern